TANBEK, K. And SANDAL, S. 2023. Dose-dependent Oxidative Damage of Molnupiravir (Antiviral Drug for Treatment of COVID-19) in Lung, Liver, Heart, and Kidney Tissues in Rats. Archives of Pharmacology and Therapeutics , vol.5, no.1 , 44-52.

TANBEK, K., & SANDAL, S., (2023). Dose-dependent Oxidative Damage of Molnupiravir (Antiviral Drug for Treatment of COVID-19) in Lung, Liver, Heart, and Kidney Tissues in Rats. Archives of Pharmacology and Therapeutics , vol.5, no.1, 44-52.

TANBEK, KEVSER, And SÜLEYMAN SANDAL. "Dose-dependent Oxidative Damage of Molnupiravir (Antiviral Drug for Treatment of COVID-19) in Lung, Liver, Heart, and Kidney Tissues in Rats," Archives of Pharmacology and Therapeutics , vol.5, no.1, 44-52, 2023

TANBEK, KEVSER And SANDAL, SÜLEYMAN. "Dose-dependent Oxidative Damage of Molnupiravir (Antiviral Drug for Treatment of COVID-19) in Lung, Liver, Heart, and Kidney Tissues in Rats." Archives of Pharmacology and Therapeutics , vol.5, no.1, pp.44-52, 2023

TANBEK, K. And SANDAL, S. (2023) . "Dose-dependent Oxidative Damage of Molnupiravir (Antiviral Drug for Treatment of COVID-19) in Lung, Liver, Heart, and Kidney Tissues in Rats." Archives of Pharmacology and Therapeutics , vol.5, no.1, pp.44-52.

@article{article, author={KEVSER TANBEK And author={SÜLEYMAN SANDAL}, title={Dose-dependent Oxidative Damage of Molnupiravir (Antiviral Drug for Treatment of COVID-19) in Lung, Liver, Heart, and Kidney Tissues in Rats}, journal={Archives of Pharmacology and Therapeutics}, year=2023, pages={44-52} }